Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was established in Shanghai under the name of Shanghai Fosun Industries Company in 1994 and officially changed its name to Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2004.
Fosun Pharma completed its initial public offering of A shares on 7 August 1998. Such shares are listed and traded on the Shanghai Stock Exchange. The stock code for Fosun Pharma’s A shares is 600196.
Fosun Pharma completed its initial public offering of H shares on 30 October 2012. Such shares are listed and traded on The Stock Exchange of Hong Kong Limited. The stock code for Fosun Pharma’s H shares is 02196.
Fosun Pharma publishes an annual report, an interim report and two quarterly reports every year.
At present, Fosun Pharma engages Ernst & Young Hua Ming as its domestic auditor and Ernst & Young as its overseas auditor.
Fosun Pharma’s financial reports for A shares can be accessed or downloaded on the official website of Shanghai Stock Exchange (http://www.sse.com.cn) and in the “Investor/Announcement” section on the official website of the Company.
Fosun Pharma’s financial reports for H shares can be accessed or downloaded on the website of The Stock Exchange of Hong Kong Limited (http://www.hkex.com.hk) and in the “Investor/Reports” section on the official website of the Company.